Difference in the recurrence rate between right- and left-sided colon cancer: A 17-year experience at a single institution

Surgery Today

Volumn 44, Issue 9, 2014, Pages 1685-1691

  Moritani, Konosuke ^a   Hasegawa, Hirotoshi ^a   Okabayashi, Koji ^a   Ishii, Yoshiyuki ^a   Endo, Takashi ^a   Kitagawa, Yuko ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Colon carcinoma; Distal colon; Prognosis; Proximal colon; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; COLON CANCER; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; RECURRENCE RISK; ANALYSIS OF VARIANCE; COLONIC NEOPLASMS; COMPARATIVE STUDY; FOLLOW UP; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; SURVIVAL RATE; TIME;

AGED; ANALYSIS OF VARIANCE; COLONIC NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECURRENCE; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84906331261     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-013-0748-5     Document Type: Article

References (20)

1. Wiggers T, Arends JW, Volovics A. Regression analysis of prognostic factors in colorectal cancer after curative resections. Dis Colon Rectum. 1988;31:33-41. (Pubitemid 18045232)
2. Steinberg SM, Barkin JS, Kaplan RS, Stablein DM. Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience. Cancer. 1986;57:1866-70. (Pubitemid 16112004)
3. Benedix F, Kube R, Meyer F, et al. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum. 2010;53:57-64.
4. Suttie SA, Shaikh I, Mullen R, et al. Outcome of right and left sided colonic and rectal cancer following surgical resection. Colorectal Dis. 2011;13:884-9.
5. Wong R. Proximal tumors are associated with greater mortality in colon cancer. J Gen Intern Med. 2010;25:1157-63.
6. Meguid RA, Slidell MB, Wolfgang CL, et al. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol. 2008;15:2388-94.
7. Wray CM, Ziogas A, Hinojosa MW, et al. Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis. Dis Colon Rectum. 2009;52:1359-66.
8. Gervaz P, Bucher P, Morel P. Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol. 2004;88:261-6. (Pubitemid 39601269)
9. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005;23:609-18. (Pubitemid 46224239)
10. Malesci A, Laghi L, Bianchi P, et al. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer. Clin Cancer Res. 2007;13:3831-9. (Pubitemid 47037588)
11. Tran B, Kopetz S, Tie J, et al. Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer. Cancer. 2011;117:4623-32.
12. Fransen K, Klintenas M, Osterstrom A, et al. Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis. 2004;25:527-33. (Pubitemid 38528645)
13. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002;137:129-31.
14. Ross WA. Colorectal cancer screening in evolution: Japan and the USA. J Gastroenterol Hepatol. 2010;25(Suppl 1):S49-56.
15. Gross CP, Andersen MS, Krumholz HM, et al. Relation between medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA. 2006;296:2815-22. (Pubitemid 44969181)
16. Park JI, Yu CS, Kim CW, et al. Prognosis and recurrent patterns of sporadic primary colon cancers according to location. J. Korean Soc.Coloproctol. 2009;25:221-26.
17. Kauh J, Brawley OW, Berger M. Racial disparities in colorectal cancer. Curr Probl Cancer. 2007;31:123-33. (Pubitemid 46818419)
18. Okabayashi K, Hasegawa H, Ishii Y, et al. Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients. Cancer Chemother Pharmacol. 2009;63:501-7.
19. Kuebler JP, Wieand HS, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol. 2007;25:2198-204. (Pubitemid 46954643)
20. Yoshida D, Ikeda Y, Waki K, et al. Different incidence of synchronous liver metastasis between proximal and distal colon cancer. Surg Today. 2012;42(5):426-30.